Beijing Strong Biotechnologies Inc Cash Flow Conversion Efficiency
Beijing Strong Biotechnologies Inc cash flow conversion efficiency. Based on the latest financial reports, Beijing Strong Biotechnologies Inc (300406) has a cash flow conversion efficiency ratio of 0.046x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥182.86 Million ≈ $26.76 Million USD) by net assets (CN¥4.00 Billion ≈ $584.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Beijing Strong Biotechnologies Inc (2011–2024)
Cash flow conversion efficiency of Beijing Strong Biotechnologies Inc from 2011 to 2024. This chart illustrates how Beijing Strong Biotechnologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Beijing Strong Biotechnologies Inc stock quote for real-time trading data and today's change.
Beijing Strong Biotechnologies Inc Cash Flow Conversion Ratio Explained
Beijing Strong Biotechnologies Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Beijing Strong Biotechnologies Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beijing Strong Biotechnologies Inc ranked by their cash flow conversion efficiency. Also see 300406 market cap for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Oriental Holdings Bhd
KLSE:4006
|
0.060x |
|
Hunan Fazhan Industrial Co Ltd
SHE:000722
|
0.026x |
|
Shandong Lukang Pharmaceutical Co Ltd
SHG:600789
|
-0.001x |
|
Smartgroup Corporation Ltd
AU:SIQ
|
0.253x |
|
Mingyue Optical Lens Co.Ltd.
SHE:301101
|
N/A |
|
Marcus & Millichap Inc
NYSE:MMI
|
0.048x |
|
Dauch Corporation
NYSE:DCH
|
-0.043x |
|
Beijing Lier High Temperature Materials Co Ltd
SHE:002392
|
0.010x |
Annual Cash Flow Conversion Efficiency for Beijing Strong Biotechnologies Inc (2011–2024)
The table below shows the annual cash flow conversion efficiency of Beijing Strong Biotechnologies Inc from 2011 to 2024. Review Beijing Strong Biotechnologies Inc (300406) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.13 Billion ≈ $604.76 Million |
CN¥614.01 Million ≈ $89.85 Million |
0.149x | -6.31% |
| 2023-12-31 | CN¥3.72 Billion ≈ $544.58 Million |
CN¥590.15 Million ≈ $86.36 Million |
0.159x | +30.84% |
| 2022-12-31 | CN¥3.27 Billion ≈ $478.32 Million |
CN¥396.17 Million ≈ $57.97 Million |
0.121x | +3.52% |
| 2021-12-31 | CN¥2.91 Billion ≈ $426.32 Million |
CN¥341.10 Million ≈ $49.91 Million |
0.117x | +225.72% |
| 2020-12-31 | CN¥3.42 Billion ≈ $500.96 Million |
CN¥123.06 Million ≈ $18.01 Million |
0.036x | -62.44% |
| 2019-12-31 | CN¥1.97 Billion ≈ $288.41 Million |
CN¥188.60 Million ≈ $27.60 Million |
0.096x | -36.41% |
| 2018-12-31 | CN¥1.70 Billion ≈ $249.09 Million |
CN¥256.15 Million ≈ $37.48 Million |
0.150x | +10.74% |
| 2017-12-31 | CN¥1.53 Billion ≈ $223.89 Million |
CN¥207.91 Million ≈ $30.42 Million |
0.136x | -22.45% |
| 2016-12-31 | CN¥1.39 Billion ≈ $203.11 Million |
CN¥243.21 Million ≈ $35.59 Million |
0.175x | +44.42% |
| 2015-12-31 | CN¥1.18 Billion ≈ $171.97 Million |
CN¥142.59 Million ≈ $20.86 Million |
0.121x | -23.69% |
| 2014-12-31 | CN¥987.03 Million ≈ $144.43 Million |
CN¥156.94 Million ≈ $22.97 Million |
0.159x | -48.55% |
| 2013-12-31 | CN¥476.31 Million ≈ $69.70 Million |
CN¥147.19 Million ≈ $21.54 Million |
0.309x | -5.02% |
| 2012-12-31 | CN¥385.67 Million ≈ $56.44 Million |
CN¥125.49 Million ≈ $18.36 Million |
0.325x | +104.63% |
| 2011-12-31 | CN¥288.66 Million ≈ $42.24 Million |
CN¥45.90 Million ≈ $6.72 Million |
0.159x | -- |
About Beijing Strong Biotechnologies Inc
Beijing Strong Biotechnologies,Inc. researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally. The company offers biochemistry reagents, including liver, renal, lipid, cardiac, diabetes, special protein, tumor marker, pancreas, inorganic, inflammation, TDM, and other panels; and coagulation products, such as prothrombin time, activ… Read more